Evolus Inc (EOLS)

Apr 18, 2025

Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | EOLS Stock News - GuruFocus

Apr 18, 2025

Apr 18, 2025

Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Apr 18, 2025

Apr 18, 2025

Evolus Strengthens Talent Strategy: 30,579 RSUs Granted to Key New Hires with 2025 Vesting - Stock Titan

Apr 18, 2025

Apr 18, 2025

Midday Stock Roundup: US Markets Closed for Good Friday - Orange County Business Journal

Apr 18, 2025

Apr 18, 2025

Evolus announces commercial launch of Evolysse - MSN

Apr 18, 2025

Apr 17, 2025

BTIG Initiates Coverage of Evolus (EOLS) with Buy Recommendation - Nasdaq

Apr 17, 2025

Apr 17, 2025

BTIG Initiates Evolus at Buy With $21 Price Target - marketscreener.com

Apr 17, 2025

Apr 17, 2025

Evolus initiated with a Buy at BTIG - TipRanks

Apr 17, 2025

Apr 17, 2025

BTIG Initiates Coverage on Evolus (EOLS) with Optimistic Outlook | EOLS Stock News - GuruFocus

Apr 17, 2025

Apr 16, 2025

Evolus Launches "Drop The F Word" To Redefine Aesthetic Injectables With Evolysse - Nasdaq

Apr 16, 2025

Apr 16, 2025

Evolus Announces Commercial Launch of Evolysse™ | EOLS Stock New - GuruFocus

Apr 16, 2025

Apr 16, 2025

Game-Changing Dermal Filler Outperforms Restylane in Clinical Trials: Evolus Expands Portfolio - Stock Titan

Apr 16, 2025

Apr 16, 2025

Evolus Launches “Drop the F Word” Campaign in Advance of the Com - GuruFocus

Apr 16, 2025

Apr 15, 2025

Game-Changing Cold-X Technology: Evolus Revolutionizes Injectable Aesthetics with Natural Results - Stock Titan

Apr 15, 2025

Apr 10, 2025

H.C. Wainwright maintains Buy on Evolus stock with $27 target - Investing.com

Apr 10, 2025

Apr 10, 2025

H.C. Wainwright maintains Buy on Evolus stock with $27 target By Investing.com - Investing.com Canada

Apr 10, 2025

Apr 09, 2025

Evolus stock hits 52-week low at $9.22 amid market challenges - Investing.com Canada

Apr 09, 2025

Apr 09, 2025

Evolus stock hits 52-week low at $9.22 amid market challenges By Investing.com - Investing.com South Africa

Apr 09, 2025

Apr 09, 2025

Midday Stock Roundup: Evolus, ICU Medical down - Orange County Business Journal

Apr 09, 2025

Apr 09, 2025

Breaking Down Evolus: 8 Analysts Share Their Views - Benzinga

Apr 09, 2025

Apr 09, 2025

Investors Give Evolus, Inc. (NASDAQ:EOLS) Shares A 31% Hiding - simplywall.st

Apr 09, 2025

Apr 08, 2025

Evolus at Needham Conference: Strategic Launch of Evolisse By Investing.com - Investing.com Canada

Apr 08, 2025

Apr 08, 2025

Evolus at Needham Conference: Strategic Launch of Evolisse - Investing.com

Apr 08, 2025

Apr 07, 2025

Sandra Beaver: Evolus on Track to Hit $700M Revenue - Orange County Business Journal

Apr 07, 2025

Apr 06, 2025

Recent 11% pullback isn't enough to hurt long-term Evolus (NASDAQ:EOLS) shareholders, they're still up 170% over 5 years - simplywall.st

Apr 06, 2025

Apr 02, 2025

Evolus, Inc.: Navigating Financial Challenges Amidst Ongoing Losses and Market Uncertainty - MSN

Apr 02, 2025

Mar 29, 2025

Evolus CEO David Moatazedi sells $77,512 in stock By Investing.com - Investing.com India

Mar 29, 2025

Mar 28, 2025

Evolus CEO David Moatazedi sells $77,512 in stock - Investing.com Australia

Mar 28, 2025

Mar 25, 2025

Evolus to Participate in The Needham 24th Annual Virtual Healthcare Conference - BioSpace

Mar 25, 2025

Mar 25, 2025

Evolus Inc (EOLS) Shares Down 4.54% on Mar 25 - GuruFocus

Mar 25, 2025

Mar 25, 2025

Evolus Leadership Reveals Growth Strategy at Major Healthcare Conference - Stock Titan

Mar 25, 2025

Mar 23, 2025

Investing in Evolus (NASDAQ:EOLS) five years ago would have delivered you a 216% gain - Yahoo Home

Mar 23, 2025

Mar 21, 2025

Evolus reports inducement grants under Nasdaq listing rule 5635(C)(4) -March 21, 2025 at 04:17 pm EDT - MarketScreener

Mar 21, 2025

Mar 21, 2025

Evolus director David Moatazedi sells $1.37 million in stock By Investing.com - Investing.com Australia

Mar 21, 2025

Mar 21, 2025

Evolus Growth Continues: 14 New Employees Join as Company Strengthens Talent Pool - Stock Titan

Mar 21, 2025

Mar 21, 2025

Evolus to Participate in Canaccord Genuity’s 43rd Annual Growth Conference - Business Wire

Mar 21, 2025

Mar 20, 2025

Evolus executive Avelar Rui sells $369,867 in stock By Investing.com - Investing.com South Africa

Mar 20, 2025

Mar 20, 2025

Evolus CFO Sandra Beaver sells $119,242 in company stock By Investing.com - Investing.com South Africa

Mar 20, 2025

Mar 20, 2025

Evolus chief marketing officer sells $60,124 in common stock By Investing.com - Investing.com South Africa

Mar 20, 2025

Mar 20, 2025

Evolus CFO Sandra Beaver sells $119,242 in company stock - Investing.com

Mar 20, 2025

Mar 20, 2025

Evolus director David Moatazedi sells $1.37 million in stock - Investing.com India

Mar 20, 2025

Mar 20, 2025

Evolus chief marketing officer sells $60,124 in common stock - Investing.com

Mar 20, 2025

Mar 20, 2025

When the Price of (EOLS) Talks, People Listen - news.stocktradersdaily.com

Mar 20, 2025

Mar 16, 2025

Trade Alert: Independent Director Of Evolus Karah Parschauer Has Sold Stock - Simply Wall St

Mar 16, 2025

Mar 15, 2025

Evolus director Parschauer sells $167,465 in common stock By Investing.com - Investing.com India

Mar 15, 2025

Mar 15, 2025

Demonstrates Effects Lasting 26 Weeks in Phase II Data Presented at 2023 ASDS Annual Meeting - Business Wire

Mar 15, 2025